mezlocillin has been researched along with tobramycin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (69.57) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Bale, M; Barrett, M; Cabezudo, I; Pfaller, MA; Wenzel, RP | 1 |
| Ramirez-Ronda, CH; Rivera-Vazquez, CR; Rodriguez, JR; Saavedra, S | 1 |
| Chastagner, P; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Patte, C; Tancrede, C | 1 |
| Cohen, MS; Faubion, C; Gordon, LI; McMahan, R; Murphy, RL; Pegram, PS; Phair, JP; Saviteer, S; Washton, H | 1 |
| Cesari, C; Cimino, M; Fenner, J; Rotstein, C; Winkey, K | 1 |
| Watanakunakorn, C | 1 |
| Mellinghoff, D; Shah, PM; Stille, W | 1 |
| Carpenter, T; Chambers, HF; Hackbarth, CJ; Kapusnik, JE; Sande, MA | 1 |
| Brooks, GF; Mordenti, J; Ries, C; Tseng, A; Unadkat, N | 1 |
| Heimann, G | 1 |
| Amgwerd, R; Rauh, G; Sonnabend, W | 1 |
| Hellriegel, KP; Kindler, J; Kress, M; Wittenberg, C | 1 |
| Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
| Bodey, GP; Issell, BF | 1 |
| Pickering, LK; Rutherford, I | 1 |
| Henderson, JL; Kline, BJ; Polk, RE | 1 |
| Eder, W; Förstl, H; Lang, M; Ruckdeschel, G | 1 |
| Danko, LS; Greenberg, RN; Meade, DW | 1 |
4 trial(s) available for mezlocillin and tobramycin
| Article | Year |
|---|---|
A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Male; Mezlocillin; Middle Aged; Pneumonia; Random Allocation; Tobramycin | 1989 |
Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Leukocyte Count; Male; Mezlocillin; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Tobramycin | 1989 |
Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Mezlocillin; Middle Aged; Neutropenia; Piperacillin; Prospective Studies; Random Allocation; Tobramycin | 1988 |
Empiric antibiotic treatment of infections in myelosuppressed cancer patients. Preliminary results.
Topics: Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefamandole; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Leukemia; Lymphoma; Mezlocillin; Middle Aged; Neoplasms; Penicillins; Prospective Studies; Random Allocation; Sisomicin; Tobramycin | 1982 |
19 other study(ies) available for mezlocillin and tobramycin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
In vitro comparison of mezlocillin and piperacillin plus tobramycin or gentamicin versus 100 gram-negative nosocomial bloodstream isolates.
Topics: Drug Synergism; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacteria; Hospitals, University; Humans; Mezlocillin; Microbial Sensitivity Tests; Piperacillin; Tobramycin | 1990 |
Role of parenteral antibiotherapy in gastrointestinal tract flora suppression. A study in children treated with high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adolescent; Agranulocytosis; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Digestive System; Dose-Response Relationship, Drug; Drug Combinations; Feces; Female; Gentamicins; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Male; Mezlocillin; Moxalactam; Sulfamethizole; Suppression, Genetic; Tobramycin; Transplantation, Autologous; Trimethoprim | 1989 |
Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
Topics: Azlocillin; Carbenicillin; Dose-Response Relationship, Drug; Drug Combinations; Gentamicins; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1986 |
[Ciprofloxacin in combination with other antimicrobial substances].
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Ciprofloxacin; Drug Interactions; Imipenem; Mezlocillin; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1988 |
Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia.
Topics: Animals; Drug Therapy, Combination; Guinea Pigs; Mezlocillin; Neutropenia; Pneumonia; Pseudomonas Infections; Tobramycin | 1988 |
Vancomycin-induced neutropenia complicating bone marrow recovery in a patient with leukemia. Case report and review of the literature.
Topics: Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Humans; Infusions, Parenteral; Leukemia, Myeloid; Male; Mezlocillin; Neutropenia; Tobramycin; Vancomycin | 1986 |
Renal toxicity of aminoglycosides in the neonatal period.
Topics: Acetylglucosaminidase; Aminoglycosides; Aminopeptidases; Ampicillin; Anti-Bacterial Agents; CD13 Antigens; Child, Preschool; gamma-Glutamyltransferase; Gentamicins; Glucuronidase; Humans; Infant; Infant, Newborn; Kidney; Kidney Tubules; Kinetics; Mezlocillin; Sepsis; Tobramycin | 1983 |
[Mezlocillin in the antibiotic therapy of severe bacterial infections in visceral surgery].
Topics: Abdomen; Adult; Aged; Bacterial Infections; Empyema; Fatty Acids; Female; Humans; Intestinal Diseases; Male; Mezlocillin; Middle Aged; Penicillins; Postoperative Complications; Surgical Wound Infection; Thoracic Surgery; Tobramycin | 1982 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
Mezlocillin for treatment of infections in cancer patients.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Drug Synergism; Humans; Immunosuppression Therapy; Mezlocillin; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Penicillins; Tobramycin | 1980 |
Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
Topics: Amdinocillin; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Gentamicins; Mezlocillin; Netilmicin; Penicillins; Piperacillin; Time Factors; Tobramycin | 1981 |
In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin.
Topics: Anti-Bacterial Agents; Azlocillin; Carbenicillin; Chemistry, Pharmaceutical; Drug Incompatibility; Gentamicins; Mezlocillin; Netilmicin; Penicillins; Temperature; Tobramycin | 1981 |
Septicemia caused by Kingella kingae.
Topics: Acute Disease; Female; Gastroenteritis; Humans; Mezlocillin; Middle Aged; Neisseriaceae; Sepsis; Tobramycin | 1984 |
Comparison of the synergic activity of aztreonam or tobramycin plus piperacillin or mezlocillin.
Topics: Aztreonam; Drug Synergism; Drug Therapy, Combination; Humans; Mezlocillin; Microbial Sensitivity Tests; Piperacillin; Tobramycin | 1993 |